See more : Oppenheimer Holdings Inc. (OPY) Income Statement Analysis – Financial Results
Complete financial analysis of Oddity Tech Ltd. (ODD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oddity Tech Ltd., a leading company in the Software – Infrastructure industry within the Technology sector.
You may be interested
- Proximus PLC (BGAOY) Income Statement Analysis – Financial Results
- Rupa & Company Limited (RUPA.NS) Income Statement Analysis – Financial Results
- Swisscom AG (0QKI.L) Income Statement Analysis – Financial Results
- Ningbo Fubang Jingye Group Co.,Ltd (600768.SS) Income Statement Analysis – Financial Results
- Mobimo Holding AG (0QQY.L) Income Statement Analysis – Financial Results
Oddity Tech Ltd. (ODD)
About Oddity Tech Ltd.
Oddity Tech Ltd., together with its subsidiaries, operates as a consumer-tech company worldwide. The company provides beauty and wellness products utilizing its PowerMatch technology. It builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company offers products for face and complexion, eyes and brows, lips, and skin care under the IL MAKIAGE brand; and hair and skin care products under the SpoiledChild brand. The company was incorporated in 2013 and is based in Tel Aviv-Jaffa, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 508.69M | 324.52M | 222.56M | 110.64M |
| Cost of Revenue | 150.46M | 106.47M | 69.37M | 32.81M |
| Gross Profit | 358.23M | 218.05M | 153.18M | 77.83M |
| Gross Profit Ratio | 70.42% | 67.19% | 68.83% | 70.34% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | -48.64M | 98.34M | 69.90M | 30.00M |
| Selling & Marketing | 125.63M | 92.05M | 63.77M | 31.17M |
| SG&A | 76.98M | 190.39M | 133.67M | 61.17M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 283.91M | 190.39M | 133.67M | 61.17M |
| Cost & Expenses | 434.37M | 296.86M | 203.04M | 93.98M |
| Interest Income | 4.28M | 371.14K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 877.00K | 1.25M |
| Depreciation & Amortization | 8.61M | 4.41M | 4.01M | 4.26M |
| EBITDA | 82.92M | 32.07M | 23.52M | 20.92M |
| EBITDA Ratio | 16.30% | 9.88% | 10.57% | 18.91% |
| Operating Income | 74.32M | 27.67M | 19.51M | 16.66M |
| Operating Income Ratio | 14.61% | 8.52% | 8.77% | 15.06% |
| Total Other Income/Expenses | 4.28M | 1.25M | -877.00K | -1.25M |
| Income Before Tax | 78.60M | 28.91M | 18.64M | 15.41M |
| Income Before Tax Ratio | 15.45% | 8.91% | 8.37% | 13.93% |
| Income Tax Expense | 20.07M | 7.18M | 4.72M | 3.70M |
| Net Income | 58.53M | 21.73M | 13.92M | 11.71M |
| Net Income Ratio | 11.51% | 6.70% | 6.25% | 10.59% |
| EPS | 1.03 | 0.11 | 0.08 | 0.06 |
| EPS Diluted | 1.00 | 0.11 | 0.08 | 0.06 |
| Weighted Avg Shares Out | 56.87M | 56.54M | 56.54M | 56.54M |
| Weighted Avg Shares Out (Dil) | 58.70M | 56.54M | 56.54M | 56.54M |
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
Earlier this year FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease Earlier this year FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease
Oddity Tech: Executing Well (Rating Upgrade)
Oddity Tech's data-driven, AI-powered DTC model looks set to facilitate market share gains through FY28. ODD's forward EV/EBITDA valuation of 16.2x is pricier than the industry average, but we feel it is worth this premium, considering the superior EBITDA profile...
This AI Stock Picks The Perfect Lipstick
AI stock Oddity hit a new buy point this week. The Israeli retailer uses AI to deliver a precise product match to customers.
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
Investors can add these top-ranked liquid stocks, American Superconductor Corporation, Angi, Sezzle and Oddity Tech, to their portfolios to boost returns.
Oddity Tech (ODD) Recently Broke Out Above the 20-Day Moving Average
From a technical perspective, Oddity Tech (ODD) is looking like an interesting pick, as it just reached a key level of support. ODD recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
Can Oddity Tech (ODD) Climb 28.74% to Reach the Level Wall Street Analysts Expect?
The mean of analysts' price targets for Oddity Tech (ODD) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside...
What Makes Oddity Tech (ODD) a New Strong Buy Stock
Oddity Tech (ODD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
L Catterton Agrees to Sell $100 Million of Shares Back to ODDITY
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced that it has entered into a transaction with a fund managed by L Catterton (“L Catterton”) to repurchase approximately 2.35 million Class A Ordinary Shares (the...
Oddity Tech Ltd (ODD) Q3 2024 Earnings Call Transcript
Oddity Tech Ltd (NASDAQ:ODD ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Maria Lycouris - Investor Relations Oran Holtzman - Co-Founder and Chief Executive Officer Lindsay Drucker Mann - Global Chief Financial Officer Conference...
Oddity Tech (ODD) Q3 Earnings and Revenues Surpass Estimates
Oddity Tech (ODD) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.21 per share a year ago.
Source: https://incomestatements.info
Category: Stock Reports